Sugemalimab offers PFS benefits for unresectable NSCLC Presented ByProf. Yi-Long Wu, Guangdong Provincial People’s Hospital, China TrialPhase 3, GEMSTONE-301 ConferenceWCLC 2022 23 August, 2022 11:10